Dementia Genetic Testing

What is Dementia?

Not a specific disease, Dementia is a group of conditions characterized by impairment of at least two brain functions, such as memory loss and judgment.

Symptoms can include limited social skills, forgetfulness, and impaired comprehension abilities, to the point that it interferes with daily functioning.

Luckily, medication and various types of therapy may help manage the symptoms of dementia. Some of the causes are even reversible, especially if caught early on.

Genetic Testing can Target the Following Conditions
  • Parkinson’s Disease (PD)
  • Gaucher Disease
  • Segawa Syndrome
  • Alpers Syndrome
  • Amyotrophic Lateral Sclerosis (ALS)
  • Alzheimer’s Disease (AD)
  • Nasu-Hakola Disease
  • Gerstmann-Straussler Disease
  • Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)

How can genetic testing really help?

People identified with a disease-causing change (a pathogenic or likely pathogenic variant) in a gene on this panel have an increased risk of developing the associated neurodegenerative disease. Genetic testing can be beneficial in the planning and decision-making process for treatment psychosocial counseling, study enrollment, and support programs for caregivers and patients. Your family members can also be tested to help define their risk. If a pathogenic variant is identified, close relatives (children, siblings, and parents) are up to 50% more likely to also be at increased risk.

Kardia Guard can help.

Kardia Guard provides simple and affordable testing. With early detection measures, providers can intervene sooner, thus paving the way to individualized care for their families.

Identify the risks early.

The Dementia Panel uses Next Generation Sequencing technology to examine 35 genes associated with an increased risk for developing neurodegenerative disease.

It will only take a minute!